The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Down here in Louisiana, we’ve got enough financial worries, especially after four years of Biden-induced inflation. Yet, ...

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald ...

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.

Mehmet Oz recently took the reins as the new head of the Centers for Medicare & Medicaid Services (CMS), which oversees health coverage for nearly half of Americans. He will be responsible for ...

Risks to BMY include potential for tariffs to raise costs of drugs manufactured outside of the U.S. Moreover, drug pricing ...